Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Acoustic and Electrical Stimulation for Tinnitus

Official title: Acoustic and Electrical Stimulation for the Treatment of Tinnitus

Run by University of California, Irvine · NCT03511807 · Data updated 2026-11-12

Researchers are testing whether specific sounds or electrical stimulation of the inner ear can reduce or eliminate tinnitus in adults who have had it for at least six months.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of California, Irvine
Academic / other
Locations1 site (Irvine, California)
StatusRecruiting
StartedJanuary 1, 2017
Main results expectedNovember 2032
Study endsNovember 2032
Registry record updatedJune 11, 2026
Trial IDNCT03511807 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with tinnitus lasting at least 6 months, able to describe sensory experiences, and, for electrical stimulation, those with a cochlear implant if applicable.

Probably not a fit

Some participants may not experience tinnitus relief with acoustic or electrical stimulation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores whether acoustic stimulation through headphones and electrical stimulation of the inner ear can suppress or eliminate tinnitus. Participants will be given sound stimuli at various frequencies and loudness levels, and report perceived tinnitus loudness at intervals. For electrical stimulation, pulse trains delivered via the inner ear will be tested to determine their effect on tinnitus. The trial includes adults 18 and older, with and without cochlear implants, and excludes those with certain medical or situational factors that could confound results. The long-term goal is to develop new methods to reduce or remove tinnitus symptoms.

Why it matters

Potential benefit: If successful, participants may experience a reduction or elimination of tinnitus symptoms through acoustic or electrical stimulation.

How similar studies have gone: Previous efforts using acoustic masking and cochlear implant approaches have shown variable results; this study tests more targeted stimulation to achieve suppression or elimination.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 18 years or older
2. Male or female
3. Tinnitus present for 6 months or more
4. Adequate command of English to reliably describe the unusual sensory percepts provided by electrical stimulation, and to complete surveys.
5. For patients undergoing electrical stimulation via a cochlear implant, they should have a cochlear implant prior to enrollment (not applicable for acoustic stimulation)

Exclusion Criteria:

1. Aged less than 18 years
2. Active illicit drug use, alcohol dependence
3. Treatable cause of tinnitus
4. History of psychosis
5. Abnormalities of the ear canal or ear drum
6. Chronic middle ear disease
7. Subjects on medications known to cause tinnitus (aspirin, ibuprofen, naproxen) which could not be stopped will be excluded.
8. Pregnant or breastfeeding.

Where it's running

  • Hamid R. Djalilian
    Irvine, California, United States
    Recruiting

Study contacts

  • Principal investigator: Hamid Djalilian, MD — University of California, Irvine
  • Study coordinator: Hamid Djalilian, MD
  • Email: tinnitus@uci.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.